Loss of SMARCB1, a subunit of the SWI/SNF complex, drives malignant rhabdoid tumors and is associated with the blocking of differentiation, reprogramming toward an oncogenic transcriptional program, and activation of cancer signaling [152, 153]. Here, SMARCA1 is linked to cancer.